cilostazol has been researched along with Diabetic Retinopathy in 8 studies
Diabetic Retinopathy: Disease of the RETINA as a complication of DIABETES MELLITUS. It is characterized by the progressive microvascular complications, such as ANEURYSM, interretinal EDEMA, and intraocular PATHOLOGIC NEOVASCULARIZATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the effects of cilostazol, an antiplatelet and vasodilation agent, on the retinal function of patients with non-proliferative diabetic retinopathy (NPDR) using a full-field electroretinogram (ffERG)." | 7.83 | The effect of cilostazol on electrophysiologic changes in non-proliferative diabetic retinopathy patients. ( Kim, HD; Kim, YK; Lee, SH; Oh, JR; Ohn, YH, 2016) |
| "To explore the effect of cilostazol in the pathophysiology of diabetic retinopathy and its mechanism, we intraperitoneal injection streptozotocin (STZ) to induce rats diabetic model to study the alteration of the thrombospondin-1 (TSP-1) in the retina of diabetic rats, cilostazol treatment diabetic rats and normal rats by immunohistochemistry, real-time quantitative reverse transcription-polymerase chain reaction." | 7.74 | The effect of cilostazol on expression of thrombospondin-1 in diabetic retinopathy. ( Gu, YS; Teng, XD; Wang, JY; Yan, LP; Zhang, XM, 2008) |
| "Treatment with cilostazol significantly reduced the ROS levels in the AqH compared to the diabetic rats." | 5.51 | Cilostazol Attenuates Retinal Oxidative Stress and Inflammation in a Streptozotocin-Induced Diabetic Animal Model. ( Chang, SW; Huang, YH; Lin, CW; Wang, LC; Yang, CH; Yang, CM; Yang, WS; Yeh, PT, 2019) |
| "To evaluate the effects of cilostazol, an antiplatelet and vasodilation agent, on the retinal function of patients with non-proliferative diabetic retinopathy (NPDR) using a full-field electroretinogram (ffERG)." | 3.83 | The effect of cilostazol on electrophysiologic changes in non-proliferative diabetic retinopathy patients. ( Kim, HD; Kim, YK; Lee, SH; Oh, JR; Ohn, YH, 2016) |
| "To explore the effect of cilostazol in the pathophysiology of diabetic retinopathy and its mechanism, we intraperitoneal injection streptozotocin (STZ) to induce rats diabetic model to study the alteration of the thrombospondin-1 (TSP-1) in the retina of diabetic rats, cilostazol treatment diabetic rats and normal rats by immunohistochemistry, real-time quantitative reverse transcription-polymerase chain reaction." | 3.74 | The effect of cilostazol on expression of thrombospondin-1 in diabetic retinopathy. ( Gu, YS; Teng, XD; Wang, JY; Yan, LP; Zhang, XM, 2008) |
| "Treatment with cilostazol significantly reduced the ROS levels in the AqH compared to the diabetic rats." | 1.51 | Cilostazol Attenuates Retinal Oxidative Stress and Inflammation in a Streptozotocin-Induced Diabetic Animal Model. ( Chang, SW; Huang, YH; Lin, CW; Wang, LC; Yang, CH; Yang, CM; Yang, WS; Yeh, PT, 2019) |
| "Cilostazol treatment may be useful for the management of diabetic retinal vascular dysfunction and neuronal degeneration." | 1.39 | Neuroprotective effects of cilostazol on retinal ganglion cell damage in diabetic rats. ( Jung, KI; Kim, JH; Park, CK; Park, HY, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nagai, N | 1 |
| Deguchi, S | 1 |
| Otake, H | 1 |
| Hiramatsu, N | 1 |
| Yamamoto, N | 1 |
| Yeh, PT | 1 |
| Huang, YH | 1 |
| Chang, SW | 1 |
| Wang, LC | 1 |
| Yang, CM | 1 |
| Yang, WS | 1 |
| Lin, CW | 1 |
| Yang, CH | 1 |
| Jung, KI | 1 |
| Kim, JH | 1 |
| Park, HY | 1 |
| Park, CK | 1 |
| Kim, HD | 1 |
| Lee, SH | 1 |
| Kim, YK | 1 |
| Oh, JR | 1 |
| Ohn, YH | 1 |
| Wang, JY | 1 |
| Gu, YS | 1 |
| Yan, LP | 1 |
| Teng, XD | 1 |
| Zhang, XM | 1 |
| Hotta, N | 1 |
| Nakamura, J | 1 |
| Sakakibara, F | 1 |
| Hamada, Y | 1 |
| Hara, T | 1 |
| Mori, K | 1 |
| Nakashima, E | 1 |
| Sasaki, H | 1 |
| Kasama, N | 1 |
| Inukai, S | 1 |
| Koh, N | 1 |
| Omoto, S | 1 |
| Nomura, S | 1 |
| Shouzu, A | 1 |
| Hayakawa, T | 1 |
| Shimizu, H | 1 |
| Miyake, Y | 1 |
| Yonemoto, T | 1 |
| Nishikawa, M | 1 |
| Fukuhara, S | 1 |
| Inada, M | 1 |
| Ahn, CW | 1 |
| Lee, HC | 1 |
| Park, SW | 1 |
| Song, YD | 1 |
| Huh, KB | 1 |
| Oh, SJ | 1 |
| Kim, YS | 1 |
| Choi, YK | 1 |
| Kim, JM | 1 |
| Lee, TH | 1 |
1 trial available for cilostazol and Diabetic Retinopathy
| Article | Year |
|---|---|
Decrease in carotid intima media thickness after 1 year of cilostazol treatment in patients with type 2 diabetes mellitus.
Topics: Blood Glucose; Blood Pressure; Carotid Artery, Common; Cilostazol; Coronary Disease; Diabetes Mellit | 2001 |
7 other studies available for cilostazol and Diabetic Retinopathy
| Article | Year |
|---|---|
Therapeutic Effect of Cilostazol Ophthalmic Nanodispersions on Retinal Dysfunction in Streptozotocin-Induced Diabetic Rats.
Topics: Animals; Cell Line; Cell Survival; Cilostazol; Diabetes Mellitus, Experimental; Diabetic Retinopathy | 2017 |
Cilostazol Attenuates Retinal Oxidative Stress and Inflammation in a Streptozotocin-Induced Diabetic Animal Model.
Topics: Animals; Aqueous Humor; Blood Glucose; Blotting, Western; Chemokine CCL2; Chemokine CX3CL1; Cilostaz | 2019 |
Neuroprotective effects of cilostazol on retinal ganglion cell damage in diabetic rats.
Topics: Animals; Apoptosis; Blood Glucose; Blotting, Western; Body Weight; Cell Death; Cilostazol; Diabetic | 2013 |
The effect of cilostazol on electrophysiologic changes in non-proliferative diabetic retinopathy patients.
Topics: Adult; Aged; Analysis of Variance; Atherosclerosis; Case-Control Studies; Cilostazol; Diabetes Melli | 2016 |
The effect of cilostazol on expression of thrombospondin-1 in diabetic retinopathy.
Topics: Animals; Cilostazol; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Immunohistochemistry; In | 2008 |
Electroretinogram in sucrose-fed diabetic rats treated with an aldose reductase inhibitor or an anticoagulant.
Topics: 2,3-Diphosphoglycerate; Aldehyde Reductase; Animals; Anticoagulants; Blood Glucose; Body Weight; Cil | 1997 |
Significance of platelet-derived microparticles and activated platelets in diabetic nephropathy.
Topics: Antigens, CD; Blood Coagulation; Blood Platelets; Case-Control Studies; Cilostazol; Diabetic Nephrop | 1999 |